Literature DB >> 34202051

HIV Infection: Time from Diagnosis to Initiation of Antiretroviral Therapy in Portugal, a Multicentric Study.

Vanessa Nicolau1, Rui Cortes2, Maria Lopes2, Ana Virgolino3,4, Osvaldo Santos3,4,5, António Martins6, Nancy Faria7, Ana Paula Reis7, Catarina Santos8, Fernando Maltez3,4,9, Álvaro Ayres Pereira3,4,10, Francisco Antunes3,4.   

Abstract

The benefits of antiretroviral therapy (ART) for persons living with HIV (PLWH) are well established. Rapid ART initiation can lead to improved clinical outcomes. Portugal has one of the highest rates of new HIV diagnoses in the European Union, and an average time until ART initiation above the recommendations established by the national guideline according to data from the first two years after its implementation in 2015, with no more recent data available after that. This study aimed to evaluate time from the first hospital appointment until ART initiation among newly diagnosed HIV patients in Portugal between 2017 and 2018, to investigate differences between hospitals, and to understand the experience of patient associations in supporting the navigation of PLWH throughout referral and linkage to the therapeutic process. To answer to these objectives, a twofold design was followed: a quantitative approach, with an analysis of records from five Portuguese hospitals, and a qualitative approach, with individual interviews with three representatives of patient associations. Overall, 847 and 840 PLWH initiated ART in 2017 and in 2018, respectively, 21 days (median of the two years) after the first appointment, with nearly half coming outside the mainstream service for hospital referral, and with observed differences between hospitals. In 2017-2018, only 38.0% of PLWH initiated ART in less than 14 days after the first hospital appointment. From the interviews, barriers of administrative and psychosocial nature were identified that may hinder access to ART. Patient associations work to offer a tailored support to patients' navigation within the health system, which can help to reduce or overcome those potential barriers. Indicators related to time until ART initiation can be used to monitor and improve access to specialized care of PLWH.

Entities:  

Keywords:  ART initiation; care cascade; care continuum; persons living with HIV; systems for referral

Year:  2021        PMID: 34202051     DOI: 10.3390/healthcare9070797

Source DB:  PubMed          Journal:  Healthcare (Basel)        ISSN: 2227-9032


  29 in total

1.  The Effect of Same-Day Observed Initiation of Antiretroviral Therapy on HIV Viral Load and Treatment Outcomes in a US Public Health Setting.

Authors:  Christopher D Pilcher; Clarissa Ospina-Norvell; Aditi Dasgupta; Diane Jones; Wendy Hartogensis; Sandra Torres; Fabiola Calderon; Erin Demicco; Elvin Geng; Monica Gandhi; Diane V Havlir; Hiroyu Hatano
Journal:  J Acquir Immune Defic Syndr       Date:  2017-01-01       Impact factor: 3.731

2.  Caution: should we be treating HIV infection early?

Authors:  J A Levy
Journal:  Lancet       Date:  1998-09-19       Impact factor: 79.321

3.  Update of Survival for Persons With HIV Infection in Denmark.

Authors:  Nicolai Lohse; Niels Obel
Journal:  Ann Intern Med       Date:  2016-11-15       Impact factor: 25.391

4.  Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial.

Authors:  Beatriz Grinsztejn; Mina C Hosseinipour; Heather J Ribaudo; Susan Swindells; Joseph Eron; Ying Q Chen; Lei Wang; San-San Ou; Maija Anderson; Marybeth McCauley; Theresa Gamble; Nagalingeshwaran Kumarasamy; James G Hakim; Johnstone Kumwenda; Jose H S Pilotto; Sheela V Godbole; Suwat Chariyalertsak; Marineide Gonçalves de Melo; Kenneth H Mayer; Susan H Eshleman; Estelle Piwowar-Manning; Joseph Makhema; Lisa A Mills; Ravindre Panchia; Ian Sanne; Joel Gallant; Irving Hoffman; Taha E Taha; Karin Nielsen-Saines; David Celentano; Max Essex; Diane Havlir; Myron S Cohen
Journal:  Lancet Infect Dis       Date:  2014-03-04       Impact factor: 25.071

5.  Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection.

Authors:  Jens D Lundgren; Abdel G Babiker; Fred Gordin; Sean Emery; Birgit Grund; Shweta Sharma; Anchalee Avihingsanon; David A Cooper; Gerd Fätkenheuer; Josep M Llibre; Jean-Michel Molina; Paula Munderi; Mauro Schechter; Robin Wood; Karin L Klingman; Simon Collins; H Clifford Lane; Andrew N Phillips; James D Neaton
Journal:  N Engl J Med       Date:  2015-07-20       Impact factor: 91.245

6.  Effect of early versus deferred antiretroviral therapy for HIV on survival.

Authors:  Mari M Kitahata; Stephen J Gange; Alison G Abraham; Barry Merriman; Michael S Saag; Amy C Justice; Robert S Hogg; Steven G Deeks; Joseph J Eron; John T Brooks; Sean B Rourke; M John Gill; Ronald J Bosch; Jeffrey N Martin; Marina B Klein; Lisa P Jacobson; Benigno Rodriguez; Timothy R Sterling; Gregory D Kirk; Sonia Napravnik; Anita R Rachlis; Liviana M Calzavara; Michael A Horberg; Michael J Silverberg; Kelly A Gebo; James J Goedert; Constance A Benson; Ann C Collier; Stephen E Van Rompaey; Heidi M Crane; Rosemary G McKaig; Bryan Lau; Aimee M Freeman; Richard D Moore
Journal:  N Engl J Med       Date:  2009-04-01       Impact factor: 91.245

7.  Time from HIV diagnosis to commencement of antiretroviral therapy as an indicator to supplement the HIV cascade: Dramatic fall from 2011 to 2015.

Authors:  Nicholas A Medland; Eric P F Chow; James H McMahon; Julian H Elliott; Jennifer F Hoy; Christopher K Fairley
Journal:  PLoS One       Date:  2017-05-16       Impact factor: 3.240

8.  Population uptake and effectiveness of test-and-treat antiretroviral therapy guidelines for preventing the global spread of HIV: an ecological cross-national analysis.

Authors:  A Mendez-Lopez; M McKee; D Stuckler; R Granich; S Gupta; T Noori; J C Semenza
Journal:  HIV Med       Date:  2019-05-29       Impact factor: 3.180

9.  Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial.

Authors:  Andrew Zolopa; Janet Andersen; William Powderly; Alejandro Sanchez; Ian Sanne; Carol Suckow; Evelyn Hogg; Lauren Komarow
Journal:  PLoS One       Date:  2009-05-18       Impact factor: 3.240

10.  Barriers to and facilitators of antiretroviral therapy adherence in Nepal: a qualitative study.

Authors:  Sharada P Wasti; Padam Simkhada; Julian Randall; Jennifer V Freeman; Edwin van Teijlingen
Journal:  J Health Popul Nutr       Date:  2012-12       Impact factor: 2.000

View more
  1 in total

1.  Effect of universal test and treat on retention and mortality among people living with HIV-infection in Uganda: An interrupted time series analysis.

Authors:  Levicatus Mugenyi; Mastula Nanfuka; Jaffer Byawaka; Collins Agaba; Andrew Mijumbi; David Kagimu; Kenneth Mugisha; Jaffer Shabbar; Michael Etukoit
Journal:  PLoS One       Date:  2022-05-17       Impact factor: 3.752

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.